<![CDATA[Eli Lilly’s Anti-Amyloid Therapy Donanemab
Gains EU Approval for Alzheimer Disease]]>
Post Content: Source: Neurology Read More
<![CDATA[Clinical Potential of Quantitative
Susceptibility Mapping MRI to Predict Cognitive
Decline]]>
Post Content: Source: Neurology Read More
<![CDATA[NeuroVoices: Carol Abraham, on Awareness,
Advocacy, and Life With LGMD]]>
Post Content: Source: Neurology Read More
<![CDATA[Ocrelizumab Shows Similar Efficacy to
Fingolimod in Phase 3 OPERETTA 2 Trial for Pediatric
Relapsing-Remitting MS]]>
Post Content: Source: Neurology Read More
<![CDATA[Amplifying Patient Voices Through LGMD
Awareness Day: Carol Abraham]]>
Post Content: Source: Neurology Read More
<![CDATA[Phase 3b GAVOTTE Trial Reveals No Added
Benefit With Higher-Dose Ocrelizumab in Primary Progressive
MS]]>
Post Content: Source: Neurology Read More
<![CDATA[Early Use and Duration of B-Cell Therapies
in Multiple Sclerosis]]>
Post Content: Source: Neurology Read More
<![CDATA[Why Subtype Matters: Genetic Testing,
Registries, and the Road to LGMD Treatments]]>
Post Content: Source: Neurology Read More







